TA

TBP Advisors Portfolio holdings

AUM $161M
1-Year Est. Return 15.39%
This Quarter Est. Return
1 Year Est. Return
+15.39%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$153M
AUM Growth
-$18.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
56
New
Increased
Reduced
Closed

Top Buys

1 +$212K
2 +$22.7K
3 +$14.5K
4
HAL icon
Halliburton
HAL
+$12.8K

Top Sells

1 +$2.61M
2 +$1.58M
3 +$1.43M
4
ADP icon
Automatic Data Processing
ADP
+$1.24M
5
NKE icon
Nike
NKE
+$1.16M

Sector Composition

1 Technology 32.87%
2 Consumer Discretionary 15.75%
3 Healthcare 10.07%
4 Financials 9.14%
5 Energy 7.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROP icon
26
Roper Technologies
ROP
$48.1B
$2.23M 1.46%
14,261
-3,110
HAL icon
27
Halliburton
HAL
$23.2B
$2.19M 1.43%
55,640
+325
QCOM icon
28
Qualcomm
QCOM
$183B
$1.73M 1.13%
23,220
-3,000
LLTC
29
DELISTED
Linear Technology Corp
LLTC
$1.53M 1%
33,549
IFN
30
India Fund
IFN
$593M
$1.11M 0.73%
43,005
XOM icon
31
Exxon Mobil
XOM
$494B
$795K 0.52%
8,600
-6,687
REGN icon
32
Regeneron Pharmaceuticals
REGN
$69.1B
$769K 0.5%
1,875
DD icon
33
DuPont de Nemours
DD
$16.7B
$740K 0.48%
8,046
MLCO icon
34
Melco Resorts & Entertainment
MLCO
$3.32B
$659K 0.43%
25,950
PAYX icon
35
Paychex
PAYX
$40.3B
$638K 0.42%
13,815
IBM icon
36
IBM
IBM
$286B
$628K 0.41%
4,095
-4,916
PG icon
37
Procter & Gamble
PG
$343B
$583K 0.38%
6,403
MRK icon
38
Merck
MRK
$214B
$539K 0.35%
9,944
DIS icon
39
Walt Disney
DIS
$199B
$441K 0.29%
4,685
-15
PEP icon
40
PepsiCo
PEP
$195B
$397K 0.26%
4,200
-3,600
T icon
41
AT&T
T
$176B
$383K 0.25%
15,107
GE icon
42
GE Aerospace
GE
$324B
$314K 0.21%
2,596
-313
MO icon
43
Altria Group
MO
$97.4B
$305K 0.2%
6,200
COF icon
44
Capital One
COF
$138B
$294K 0.19%
3,566
EMR icon
45
Emerson Electric
EMR
$72.9B
$284K 0.19%
4,600
ED icon
46
Consolidated Edison
ED
$35.5B
$277K 0.18%
4,200
MSFT icon
47
Microsoft
MSFT
$3.69T
$235K 0.15%
5,055
UNP icon
48
Union Pacific
UNP
$131B
$212K 0.14%
+1,778
A icon
49
Agilent Technologies
A
$41.6B
-6,516
ABBV icon
50
AbbVie
ABBV
$387B
-6,564